drugset / Trial / NCT02992496

Investigation of Antidepressant Efficacy of Oral Ketamine Treatment

NCT02992496

Phase 2 Unknown 60 enrolled Medical University of Vienna
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this double-blind, controlled, randomized study is to investigate the antidepressant efficacy of oral ketamine treatment in patients suffering from a major depressive episode.

Timeline

Start
2017-04-24
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 1 mg/kg Oral
Comparator Midazolam Small molecule 0.03 mg/kg